Literature DB >> 18472874

Permeability of blood-tear barrier to fluorescein and albumin after application of platelet-activating factor to the eye of the guinea pig.

J L van Delft1, F Meijer, J A van Best, N J van Haeringen.   

Abstract

One of the inflammatory responses of the eye to local application of platelet-activating factor (PAF) is oedema of the conjunctiva, caused by extravasation of plasma. Aim of the study was to investigate if fluorescein would leak from the blood into the tears together with plasma protein after application of PAF to the eye. Fluorescein was given intraperitoneally 30 min prior to application of 25 microl of 0.1% solution of PAF. Thirty min after PAF the tear film was collected by washing the surface of the eye with 25 microl of phosphate buffered saline (PBS). Fluorescein in eye washings and in plasma was measured by fluorophotometry and albumin by immunodiffusion. Both fluorescein and albumin appeared in a related fashion in tears, being absent in washings of placebo-treated control eyes. Extravasation of fluorescein can be used as a measure for plasma leakage in the conjunctiva with the advantage over the Evans Blue method that the former is a non-invasive method.

Entities:  

Year:  1997        PMID: 18472874      PMCID: PMC2365880          DOI: 10.1080/09629359791532

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  5 in total

1.  Synthesis of platelet activating factor by ocular tissue from inflamed eyes.

Authors:  J T Rosenbaum; R S Boney; J R Samples; F H Valone
Journal:  Arch Ophthalmol       Date:  1991-03

2.  Comparison of tears and lacrimal gland fluid in the rabbit and guinea pig.

Authors:  L Thörig; E J van Agtmaal; E Glasius; K L Tan; N J van Haeringen
Journal:  Curr Eye Res       Date:  1985-08       Impact factor: 2.424

3.  Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.

Authors:  S B Hwang; C L Li; M H Lam; T Y Shen
Journal:  Lab Invest       Date:  1985-06       Impact factor: 5.662

Review 4.  Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy.

Authors:  M B Abelson; K Schaefer
Journal:  Surv Ophthalmol       Date:  1993 Jul-Aug       Impact factor: 6.048

5.  Platelet-activating factor: an inflammatory mediator in the acute phase of allergic conjunctivitis in a guinea-pig model.

Authors:  F Meijer; J L Delft; N J Haeringen
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

  5 in total
  3 in total

1.  Tear Fluid Pharmacokinetics Following Oral Prednisone Administration in Dogs With and Without Conjunctivitis.

Authors:  Lionel Sebbag; Yuqi Yan; Joe S Smith; Rachel A Allbaugh; Larry W Wulf; Jonathan P Mochel
Journal:  J Ocul Pharmacol Ther       Date:  2019-05-09       Impact factor: 2.671

Review 2.  Wearable Smart Contact Lenses for Continual Glucose Monitoring: A Review.

Authors:  Mohamed Elsherif; Rosalia Moreddu; Fahad Alam; Ahmed E Salih; Israr Ahmed; Haider Butt
Journal:  Front Med (Lausanne)       Date:  2022-04-04

3.  Wearables in Medicine.

Authors:  Ali K Yetisen; Juan Leonardo Martinez-Hurtado; Barış Ünal; Ali Khademhosseini; Haider Butt
Journal:  Adv Mater       Date:  2018-06-11       Impact factor: 30.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.